About the program

The Clinician Scientist Program is a modern career pathway within academic medicine that allows physicians to pursue a structured residency with time set aside for clinical and basic research. At the end of the program, participants will have completed their residency and, ideally, their postdoctoral teaching qualification (Habilitation). The program is intended to produce a new generation of scientists with translational training who will help speed up the rate at which scientific findings are translated into application. 

The program offers two tracks: a Clinician Scientist track (see Clinician Scientists), and a Junior Clinician Scientist track (see Junior Clinician Scientists). The Junior Clinician Scientist track is aimed at physicians in the first, second, or third year of their residency. The Clinician Scientist track is for physicians in their fourth year and above. In total, 103 individuals are currently receiving funding – 65 in the Clinician Scientist Program, and 38 in the Junior Clinician Program.

Background

The Clinician Scientist Program began in 2011 as the “Friedrich C. Luft” Clinical Scientist Pilot Program (with funding from the Volkswagen Stiftung and the Stiftung Charité). After a successful pilot phase, the program continued to grow, thanks to support from the medical faculty at Charité – Universitätsmedizin Berlin and from the Charité Foundation, the Johanna Quandt Private Excellence Initiative, the Berlin-Brandenburg School for Regenerative Therapies (BSRT), the Berlin School of Integrative Oncology (BSIO), the NeuroCure Cluster of Excellence, and BIH. The program was integrated into the BIH Biomedical Academy in 2015, and since then it has been known as the BIH Charité Clinician Scientist Program.